Two DFSP cases associated with germline P/LP variants of CHEK2 and 1 case associated with the CHEK2 VUS p.(Glu64Lys) were diagnosed between ages 30 to 39 (Supplemental Table 2). Here, CHEK2 is linked to dermatofibrosarcoma protuberans.